U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07835295) titled 'REMIfentanil (2 vs. 4 mcg/kg) Facilitated Intubation Without Neuromuscular Blockade Versus Succinylcholine and Rocuronium With Sugammadex for Endotracheal Intubation in Spine Surgery Requiring Motor Evoked Potential Monitoring' on Sept. 14.
Brief Summary: The purpose of this research is to compare four commonly used anesthesia medication strategies for placing a breathing tube in patients undergoing spine surgery that requires motor evoked potential (MEP) monitoring.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Airway Management
Endotracheal Intubation
Intervention:
DRUG: Low-Dose Remifentanil
Remifent...